- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads? ; volume:11 ; number:1 ; day:18 ; month:7 ; year:2024 ; pages:1-39 ; date:12.2024
EJNMMI Physics ; 11, Heft 1 (18.7.2024), 1-39, 12.2024
- Creator
-
Vergnaud, Laure
Dewaraja, Yuni K.
Giraudet, Anne-Laure
Badel, Jean-Noël
Sarrut, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-024-00658-8
- URN
-
urn:nbn:de:101:1-2410080802591.403668555375
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vergnaud, Laure
- Dewaraja, Yuni K.
- Giraudet, Anne-Laure
- Badel, Jean-Noël
- Sarrut, David
- SpringerLink (Online service)
Other Objects (12)
![Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry](/assets/placeholder/searchResultMediaUnknown.png)
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Tumor dosimetry using 177Lu: influence of background activity, measurement method and reconstruction algorithm
Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Effiziente MapReduce-Parallelisierung von Entity Resolution-Workflows
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Tumor dosimetry using 177Lu: influence of background activity, measurement method and reconstruction algorithm
Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Effiziente MapReduce-Parallelisierung von Entity Resolution-Workflows
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Tumor dosimetry using 177Lu: influence of background activity, measurement method and reconstruction algorithm
Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
Effiziente MapReduce-Parallelisierung von Entity Resolution-Workflows
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy